Transcription factor Ets-1 is essential for mesangial matrix remodeling
- 1 July 2006
- journal article
- Published by Elsevier in Kidney International
- Vol. 70 (2) , 298-305
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- DNAzyme for TGF-β suppressed extracellular matrix accumulation in experimental glomerulonephritisKidney International, 2004
- Mesangial cell expression of proto-oncogene Ets-1 during progression of mesangioproliferative glomerulonephritisKidney International, 2004
- Ets1 Is an Effector of the Transforming Growth Factor β (TGF-β) Signaling Pathway and an Antagonist of the Profibrotic Effects of TGF-βJournal of Biological Chemistry, 2002
- Role of transcription factor Ets‐1 in the apoptosis of human vascular endothelial cellsJournal of Cellular Physiology, 2001
- Properties of Two VEGF Receptors, Flt‐1 and KDR, in Signal TransductionaAnnals of the New York Academy of Sciences, 2000
- Progressive Renal Disease: Fibroblasts, Extracellular Matrix, and IntegrinsNephron Experimental Nephrology, 1999
- Induction of Ets-1 in endothelial cells during reendothelialization after denuding injuryJournal of Cellular Physiology, 1998
- Synergistic Transcriptional Activation of the Tissue Inhibitor of Metalloproteinases-1 Promoter via Functional Interaction of AP-1 and Ets-1 Transcription FactorsJournal of Biological Chemistry, 1996
- Epitope-specific induction of mesangial lesions with proteinuria by a MoAb against mesangial cell surface antigenClinical and Experimental Immunology, 1992
- Distribution of type I collagen in human kidney diseases in comparison with type III collagenThe Journal of Pathology, 1990